4
Changes in Ownership
Vaxcyte, Inc. Filed Acc 0001960048-26-000013
SVP, Finance & CAO sold 19,000 shares at $86.74 ($1,648,060)
- SVP, Finance & CAO acquired 19,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Cowan Elvia · SVP, Finance & CAO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-10-05 | Exercise or conversion : show line 1 in the form 10b5-1 | +19,000 | $25.92 | $492,480 | 46,860 | D |
| 2026-10-05 | Sale : show line 2 in the form 10b5-1 | −19,000 | $86.74 | $1,648,060 | 27,860 | D |
| Open-market sales · 19,000 sh · avg $86.74 · $1,648,060 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-10-05 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) | −19,000 | 74,068 | D |
Loading xslF345X06/wk-form4_1791403671.xml…